Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-11-21

Clinical Trial Update: Pharmacokinetic Interactions Between Buprenorphine and Tipranavir/Ritonavir [NA]

View source ↗

Summary

A completed clinical trial evaluating pharmacokinetic interactions between buprenorphine and tipranavir/ritonavir in HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • buprenorphine (buprenorphine)
  • tipranavir/ritonavir (tipranavir/ritonavir)

Snippet

Sponsor: Yale University | Conditions: HIV Infections | NA | Status: COMPLETED | Results posted: 2012-11-21